BioCryst stock forecast
BioCryst (BO1) Stock Forecast & Price Target
BO1 Analyst Ratings
BO1 Stock 12 Month Forecast
Average Price Target
€15.37▲(123.68% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Laura Chico | Wedbush | €18.08→€15.37 | buy | 123.68%Upside | Reiterated | 11/05/26 | ||
| Brian Abrahams | RBC Capital | €9.94 | hold | 44.73%Upside | Reiterated | 11/04/26 | ||
| Stacy Ku | TD Cowen | €27.12 | buy | 294.73%Upside | Reiterated | 10/21/26 | ||
| Tazeen Ahmad | Bank of America Securities | €13.56 | buy | 97.36%Upside | Reiterated | 10/09/26 | ||
| Jessica Fye | J.P. Morgan | €10.85→€11.75 | hold | 71.05%Upside | Assigned | 09/30/26 | ||
| Serge Belanger | Needham | €14.46 | buy | 110.52%Upside | Reiterated | 09/08/26 | ||
| Evercore ISI | €15.37 | buy | 123.68%Upside | Reiterated | 08/10/26 | |||
| Andrew Fein | H.C. Wainwright | €28.93 | buy | 321.04%Upside | Reiterated | 08/06/26 | ||
| Steven Seedhouse | Cantor Fitzgerald | €24.41→€26.21 | buy | 281.57%Upside | Reiterated | 06/30/26 | ||
| Jonathan Wolleben | Citizens JMP | €22.60→€25.31 | buy | 268.41%Upside | Reiterated | 05/07/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Laura ChicoWedbush | BuyReiterated€18.08→€15.37 | 11/05/26 | 123.68%Upside | ||
| Brian AbrahamsRBC Capital | HoldReiterated€9.94 | 11/04/26 | 44.73%Upside | ||
| Stacy KuTD Cowen | BuyReiterated€27.12 | 10/21/26 | 294.73%Upside | ||
| Tazeen AhmadBank of America Securities | BuyReiterated€13.56 | 10/09/26 | 97.36%Upside | ||
| Jessica FyeJ.P. Morgan | HoldAssigned€10.85→€11.75 | 09/30/26 | 71.05%Upside | ||
| Serge BelangerNeedham | BuyReiterated€14.46 | 09/08/26 | 110.52%Upside | ||
| BuyReiterated€15.37 | 08/10/26 | 123.68%Upside | |||
| Andrew FeinH.C. Wainwright | BuyReiterated€28.93 | 08/06/26 | 321.04%Upside | ||
| Steven SeedhouseCantor Fitzgerald | BuyReiterated€24.41→€26.21 | 06/30/26 | 281.57%Upside | ||
| Jonathan WollebenCitizens JMP | BuyReiterated€22.60→€25.31 | 05/07/26 | 268.41%Upside |
Best Analysts Covering BioCryst
Copying Tazeen Ahmad's trades and holding each position for 3 Months would result in 44.44% of your transactions generating a profit, with an average return of -0.27% per trade.
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of +3.58% per trade.
Copying Serge Belanger's trades and holding each position for 2 Years would result in 52.00% of your transactions generating a profit, with an average return of +6.95% per trade.
BO1 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 9 | 8 | 4 |
| Buy | 2 | 2 | 2 | 1 | 0 |
| Hold | 1 | 1 | 3 | 3 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 15 | 15 | 14 | 12 | 8 |
In the current month, BO1 has received 4 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. BO1 average Analyst price target in the past 3 months is 15.37.
BO1 Financial Forecast
BO1 Earnings Forecast
Next quarter’s earnings estimate for BO1 is EUR 0.08 with a range of EUR 0.00 to EUR 0.14. The previous quarter’s EPS was EUR 0.13. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
BO1 Sales Forecast
Next quarter’s sales forecast for BO1 is EUR 149.37M with a range of EUR 143.83M to EUR 156.27M. The previous quarter’s sales results were EUR 162.97M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

